Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Astrana Health
NasdaqCM:ASTH Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Astrana Health
Popular
Undervalued
Overvalued
Astrana Health
WA
Analyst Price Target
Consensus Narrative from 10 Analysts
Collaborative Health Systems Acquisition Will Expand Patient Reach
Key Takeaways Strategic acquisitions and network expansion could drive revenue growth and improve EBITDA through increased patient reach and service provision efficiencies. Focus on technology-enabled care management and full risk arrangements may enhance cost control and boost net margins.
View narrative
US$62.10
FV
42.5% undervalued
intrinsic discount
23.96%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
ASTH
Astrana Health
Your Fair Value
US$
Current Price
US$35.68
36.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.8b
Earnings US$136.6m
Advanced
Set as Fair Value